Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020.
Denny TN, Andrews L, Bonsignori M, Cavanaugh K, Datto MB, Deckard A, DeMarco CT, DeNaeyer N, Epling CA, Gurley T, Haase SB, Hallberg C, Harer J, Kneifel CL, Lee MJ, Louzao R, Moody MA, Moore Z, Polage CR, Puglin J, Spotts PH, Vaughn JA, Wolfe CR. Denny TN, et al. Among authors: datto mb. MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1743-1747. doi: 10.15585/mmwr.mm6946e1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33211678 Free PMC article.
Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area.
Lewis SS, Smith BA, Akinboyo IC, Seidelman J, Wolfe C, Kirk AB, Martin G, Denny T, Lobaugh B, Rehder C, Cardona D, Lee MJ, Polage CR, Datto MB. Lewis SS, et al. Among authors: datto mb. Infect Control Hosp Epidemiol. 2021 Mar;42(3):341-343. doi: 10.1017/ice.2020.398. Epub 2020 Aug 3. Infect Control Hosp Epidemiol. 2021. PMID: 32741409 Free PMC article.
Mapping SARS-CoV-2 antigenic relationships and serological responses.
Wilks SH, Mühlemann B, Shen X, Türeli S, LeGresley EB, Netzl A, Caniza MA, Chacaltana-Huarcaya JN, Corman VM, Daniell X, Datto MB, Dawood FS, Denny TN, Drosten C, Fouchier RAM, Garcia PJ, Halfmann PJ, Jassem A, Jeworowski LM, Jones TC, Kawaoka Y, Krammer F, McDanal C, Pajon R, Simon V, Stockwell MS, Tang H, van Bakel H, Veguilla V, Webby R, Montefiori DC, Smith DJ. Wilks SH, et al. Among authors: datto mb. Science. 2023 Oct 6;382(6666):eadj0070. doi: 10.1126/science.adj0070. Epub 2023 Oct 6. Science. 2023. PMID: 37797027
Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis.
Crow J, Youens K, Michalowski S, Perrine G, Emhart C, Johnson F, Gerling A, Kurtzberg J, Goodman BK, Sebastian S, Rehder CW, Datto MB. Crow J, et al. Among authors: datto mb. J Mol Diagn. 2010 Jul;12(4):530-7. doi: 10.2353/jmoldx.2010.090215. Epub 2010 Apr 29. J Mol Diagn. 2010. PMID: 20431036 Free PMC article. Review.
Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
Wang E, Papalas J, Hutchinson CB, Kulbacki E, Huang Q, Sebastian S, Rehder C, Silbermins D, Moore J, Datto M. Wang E, et al. Am J Surg Pathol. 2011 Mar;35(3):457-63. doi: 10.1097/PAS.0b013e3182098799. Am J Surg Pathol. 2011. PMID: 21317718
Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature.
Wang E, Hutchinson CB, Huang Q, Lu CM, Crow J, Wang FF, Sebastian S, Rehder C, Lagoo A, Horwitz M, Rizzieri D, Yu J, Goodman B, Datto M, Buckley P. Wang E, et al. Am J Clin Pathol. 2011 Apr;135(4):525-40. doi: 10.1309/AJCPPJUQ9DNR1GHP. Am J Clin Pathol. 2011. PMID: 21411775 Review.
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
Lanasa MC, Davis PH, Datto M, Li Z, Gockerman JP, Moore JO, DeCastro CM, Friedman DR, Diehl LF, Rehder C, Cook H, Daugherty FJ, Matta KM, Weinberg JB, Rizzieri D. Lanasa MC, et al. Leuk Lymphoma. 2012 Feb;53(2):218-24. doi: 10.3109/10428194.2011.610012. Epub 2011 Sep 23. Leuk Lymphoma. 2012. PMID: 21827374
72 results